NEW YORK, NY / ACCESSWIRE / December 17, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: RTI Surgical Inc. (RTIX), Neos Therapeutics Inc. (NEOS), Uranium Energy Corp. (UEC) and Paratek Pharmaceuticals Inc. (PRTK). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
To access our full PDF Research Packages for free, please visit the links below.
Full PDF DOWNLOAD Links
(You may have to copy and paste the links into your browser)
RTIX Research Package: http://www.traders-choice.com/pdf?s=RTIX
NEOS Research Package: http://www.traders-choice.com/pdf?s=NEOS
UEC Research Package: http://www.traders-choice.com/pdf?s=UEC
PRTK Research Package: http://www.traders-choice.com/pdf?s=PRTK
Highlights from today's reports include:
On Wednesday, December 16, 2015, the NASDAQ Composite ended at 5,071.13, up 1.52%, the Dow Jones Industrial Average advanced 1.28% to finish the day at 17,749.09 and the S&P 500 closed at 2,073.07, up 1.45%.
- RTI Surgical Inc.'s stock edged higher by 0.54% to close Wednesday's session at USD 3.70. The company's shares oscillated between USD 3.67 and USD 3.75. The stock recorded a trading volume of 0.31 million shares, which was below its 50-day daily average volume of 0.34 million shares but above its 52-week average volume of 0.25 million shares. Over the last three days, RTI Surgical Inc.'s shares have declined by 2.63% and in the past one week the stock has moved down 3.65%. Furthermore, over the last three months the stock has lost 39.44% and in the past six months the shares have shed 43.43%. Further, the shares are trading at a price to earnings ratio of 24.67 and a price to book ratio of 1.20. Additionally, the stock is trading at a price to cash flow ratio of 5.80 and price to sales ratio of 0.77. Moreover, RTI Surgical Inc. is trading below its 50-day moving average of USD 3.93.
- The stock of Neos Therapeutics Inc. gained 1.51% to close Wednesday's session at USD 12.79. The shares of the company moved in the range of USD 12.59 and USD 14.03. A trading volume of 0.09 million shares was below its 52-week average volume of 0.16 million shares. Over the last one week, Neos Therapeutics Inc.'s shares have declined by 11.55% and in the past one month the stock has lost 11.30%. Additionally, over the last three months, the stock has declined 44.15%. Further, the stock is trading at a price to sales (TTM) ratio of 78.19 and a price to book (MRQ) ratio of 2.29. Moreover, the stock is trading below its 50-day and 200-day moving average of USD 14.43 and USD 18.56, respectively. Neos Therapeutics Inc. has a market capitalization of USD 203.91 million.
- Uranium Energy Corp.'s stock remained flat to finish Wednesday's session at USD 1.02, below its 50-day and 200-day moving averages of USD 1.09 and USD 1.55, respectively. The company's shares fluctuated in the range of USD 1.00 and USD 1.05. A total of 1.13 million shares exchanged hands, which surpassed its 50-day daily average volume of 0.58 million shares and was below its 52-week average volume of 1.15 million shares. Over the last three days, Uranium Energy Corp.'s shares have declined by 1.92% and in the past one week, the stock has moved down 4.67%. Furthermore, over the last three months, the stock has lost 12.82% and in the past six months, the shares have shed 60.77%. Additionally, the stock is trading at a price to book ratio of 3.22, as against a historical PB ratio of 4.23. The company is trading at a price to sales ratio of 32.87.
- Paratek Pharmaceuticals Inc.'s stock added 1.18% to end Wednesday's session at USD 17.13. The stock traded much below its 50-day and 200-day moving averages of USD 19.20 and USD 24.92, respectively. The company's shares oscillated between USD 16.99 and USD 17.64. The stock recorded a trading volume of 0.06 million shares, which was above its 50-day daily average volume of 0.05 million shares and below its 52-week average volume of 0.07 million shares. Over the last five days, Paratek Pharmaceuticals Inc.'s shares have advanced 0.23% and in the past one month, the shares have gained a momentum of 9.25%. However, over the last three months, the stock has lost 32.93% and year to date, the shares have shed 55.56%. In addition, Paratek Pharmaceuticals Inc. is trading at a price to book ratio of 2.5 while the price to sales ratio stood at 62.3.
About Trader's Choice:
Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
TC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.
TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.
TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.
For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com
SOURCE: Trader's Choice